AIDS WEEKLY Plus - December 2001Important note: Information in this article was accurate in December 2001. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

AIDS and HIV Dementia: Verbal Memory Impaired From Early Infection Stages

AIDSWEEKLY Plus; Monday, December 17, 2001
Michael Greer, Senior Medical Writer


NewsRx -- Researchers in the United States have shown that HIV infection produces a marked impairment in verbal cognitive function.

"Verbal working memory (WM), which relies on intact functioning of frontostriatal circuits, has been suggested as a cognitive domain that is preferentially affected in HIV-1 infection," explained M.K. York and colleagues at Baylor College of Medicine in Houston, Texas.

York and coauthors found evidence that verbal WM is degraded even in early asymptomatic stages of infection and that this impairment worsens as the disease progresses.

They used the working memory model developed by British psychologist Alan Baddely in the early 1970s. By Baddely's tests for measuring the "phonological store," symptomatic HIV patients displayed a reduced capacity for short-term storage of verbal phonological information, study data showed.

Phonological storage ability in asymptomatic patients appeared to be normal, York and coworkers noted. However, both symptomatic and asymptomatic HIV patients had deficiencies in their verbal memory spans.

Articulatory control was not affected by HIV infection in the patients studied (Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals, Psychol Med 2001 Oct;31(7):1279-91.

"These findings suggest that deficits in simultaneous short-term storage and processing occur during both early and later stages of HIV-1 infection," York and associates concluded.

The corresponding author for this report is W.M. York, Department of Neurosurgery, Baylor College of Medicine, Houston, TX 77030, USA.

Key points reported in this study include

This article was prepared by AIDS Weekly editors from staff and other reports.

011217
AW011207


Copyright © 2001 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990,2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.